Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) shares fell 1.9% during mid-day trading on Wednesday . The stock traded as low as $1.29 and last traded at $1.29. 514 shares were traded during trading, a decline of 79% from the average session volume of 2,420 shares. The stock had previously closed at $1.32.
Relief Therapeutics Stock Performance
The firm has a 50 day moving average price of $1.38 and a 200-day moving average price of $1.66.
Relief Therapeutics Company Profile
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Read More
- Five stocks we like better than Relief Therapeutics
- How to Use the MarketBeat Stock Screener
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Compound Interest and Why It Matters When Investing
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Using the MarketBeat Dividend Yield Calculator
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
